PAIGE MALICK: Open Payments
NPI 1083213102 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 67 payments from 16 companies in 2025. Trend: 2023 $1,569 · 2024 $1,924 · 2025 $1,280
Food & beverage: $1,280
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $337 |
| Novo Nordisk Inc | 18 | $312 |
| GlaxoSmithKline, LLC. | 15 | $211 |
| Lilly USA, LLC | 5 | $90 |
| ABBVIE INC. | 4 | $65 |
| Amgen Inc. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| GENZYME CORPORATION | 1 | $28 |
| Seqirus USA Inc | 1 | $27 |
| Exact Sciences Corporation | 1 | $22 |
Products named: AIRSUPRA, Ozempic, TRELEGY ELLIPTA, Wegovy, NUCALA, FARXIGA, MOUNJARO, Rybelsus.
Industry payments across FL — which companies pay providers there.
